Colgate-Palmolive Analysts Increase Their Forecasts After Upbeat Results

Core Insights - Colgate-Palmolive Co reported better-than-expected first-quarter FY25 earnings, with sales of $4.91 billion, a 3% year-over-year decline, surpassing analyst expectations of $4.86 billion [1] - The non-GAAP EPS of $0.91 exceeded the consensus estimate of $0.86 [1] Financial Performance - For FY25, Colgate anticipates net sales growth in the low single digits, factoring in a negative impact from foreign exchange in the low single digits [3] - The company projects organic sales growth to be between 2% to 4% [3] - Following the earnings announcement, Colgate shares fell by 3%, trading at $91.08 [3] Analyst Ratings and Price Targets - JP Morgan analyst Andrea Teixeira maintained an Overweight rating on Colgate-Palmolive and raised the price target from $95 to $103 [7] - Citigroup analyst Filippo Falorni maintained a Buy rating and increased the price target from $103 to $108 [7] Strategic Outlook - The CEO, Noel Wallace, acknowledged challenges due to uncertainty and volatility in global markets, including tariff impacts, but expressed confidence in the company's strategy to meet revised 2025 financial targets [2]